135 related articles for article (PubMed ID: 30976795)
1. Prognostic significance of human telomerase reverse transcriptase promoter region mutations C228T and C250T for overall survival in spinal chordomas.
Bettegowda C; Yip S; Jiang B; Wang WL; Clarke MJ; Lazary A; Gambarotti M; Zhang M; Sciubba DM; Wolinsky JP; Goodwin CR; McCarthy E; Germscheid NM; Sahgal A; Gokaslan ZL; Boriani S; Varga PP; Fisher CG; Rhines LD
Neuro Oncol; 2019 Aug; 21(8):1005-1015. PubMed ID: 30976795
[TBL] [Abstract][Full Text] [Related]
2. Expression level of hTERT is regulated by somatic mutation and common single nucleotide polymorphism at promoter region in glioblastoma.
Park CK; Lee SH; Kim JY; Kim JE; Kim TM; Lee ST; Choi SH; Park SH; Kim IH
Oncotarget; 2014 May; 5(10):3399-407. PubMed ID: 24930669
[TBL] [Abstract][Full Text] [Related]
3. Distinct TERT promoter C228T and C250T mutations in a patient with an oligodendroglioma: A case report.
Ishi Y; Okada H; Okamoto M; Motegi H; Tanaka S; Mitsuhashi T; Yamaguchi S
Neuropathology; 2021 Jun; 41(3):236-242. PubMed ID: 33899270
[TBL] [Abstract][Full Text] [Related]
4.
Arantes LMRB; Cruvinel-Carloni A; de Carvalho AC; Sorroche BP; Carvalho AL; Scapulatempo-Neto C; Reis RM
Front Oncol; 2020; 10():1275. PubMed ID: 32850388
[No Abstract] [Full Text] [Related]
5. TERT promoter mutation as an early genetic event activating telomerase in follicular thyroid adenoma (FTA) and atypical FTA.
Wang N; Liu T; Sofiadis A; Juhlin CC; Zedenius J; Höög A; Larsson C; Xu D
Cancer; 2014 Oct; 120(19):2965-79. PubMed ID: 24898513
[TBL] [Abstract][Full Text] [Related]
6. Chordoma of the skull base: predictors of tumor recurrence.
Pallini R; Maira G; Pierconti F; Falchetti ML; Alvino E; Cimino-Reale G; Fernandez E; D'Ambrosio E; Larocca LM
J Neurosurg; 2003 Apr; 98(4):812-22. PubMed ID: 12691407
[TBL] [Abstract][Full Text] [Related]
7. The activating TERT promoter mutation C228T is recurrent in subsets of adrenal tumors.
Liu T; Brown TC; Juhlin CC; Andreasson A; Wang N; Bäckdahl M; Healy JM; Prasad ML; Korah R; Carling T; Xu D; Larsson C
Endocr Relat Cancer; 2014 Jun; 21(3):427-34. PubMed ID: 24803525
[TBL] [Abstract][Full Text] [Related]
8. Upregulated human telomerase reverse transcriptase (hTERT) expression is associated with spinal chordoma growth, invasion and poor prognosis.
Zou MX; Lv GH; Li J; She XL; Jiang Y
Am J Transl Res; 2016; 8(2):516-29. PubMed ID: 27158344
[TBL] [Abstract][Full Text] [Related]
9. hTERT promoter mutations in chondrosarcomas associate with progression and disease-related mortality.
Lin Y; Seger N; Chen Y; Hesla AC; Wejde J; Ghaderi M; Tsagkozis P; Larsson O; Haglund F
Mod Pathol; 2018 Dec; 31(12):1834-1841. PubMed ID: 30065261
[TBL] [Abstract][Full Text] [Related]
10. Common telomerase reverse transcriptase promoter mutations in hepatocellular carcinomas from different geographical locations.
Cevik D; Yildiz G; Ozturk M
World J Gastroenterol; 2015 Jan; 21(1):311-7. PubMed ID: 25574106
[TBL] [Abstract][Full Text] [Related]
11. Human TERT promoter mutation enables survival advantage from MGMT promoter methylation in IDH1 wild-type primary glioblastoma treated by standard chemoradiotherapy.
Nguyen HN; Lie A; Li T; Chowdhury R; Liu F; Ozer B; Wei B; Green RM; Ellingson BM; Wang HJ; Elashoff R; Liau LM; Yong WH; Nghiemphu PL; Cloughesy T; Lai A
Neuro Oncol; 2017 Mar; 19(3):394-404. PubMed ID: 27571882
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Significance of TERT Promoter Mutations in Papillary Thyroid Carcinomas in a BRAF(V600E) Mutation-Prevalent Population.
Lee SE; Hwang TS; Choi YL; Han HS; Kim WS; Jang MH; Kim SK; Yang JH
Thyroid; 2016 Jul; 26(7):901-10. PubMed ID: 27184112
[TBL] [Abstract][Full Text] [Related]
13. Cytogenetic, telomere, and telomerase studies in five surgically managed lumbosacral chordomas.
Butler MG; Dahir GA; Hedges LK; Juliao SF; Sciadini MF; Schwartz HS
Cancer Genet Cytogenet; 1995 Nov; 85(1):51-7. PubMed ID: 8536238
[TBL] [Abstract][Full Text] [Related]
14. Spinal column chordoma: prognostic significance of clinical variables and T (brachyury) gene SNP rs2305089 for local recurrence and overall survival.
Bettegowda C; Yip S; Lo SL; Fisher CG; Boriani S; Rhines LD; Wang JY; Lazary A; Gambarotti M; Wang WL; Luzzati A; Dekutoski MB; Bilsky MH; Chou D; Fehlings MG; McCarthy EF; Quraishi NA; Reynolds JJ; Sciubba DM; Williams RP; Wolinsky JP; Zadnik PL; Zhang M; Germscheid NM; Kalampoki V; Varga PP; Gokaslan ZL;
Neuro Oncol; 2017 Mar; 19(3):405-413. PubMed ID: 27663388
[TBL] [Abstract][Full Text] [Related]
15. Advances in Detecting Low Prevalence Somatic
da Costa VR; Bim LV; Pacheco E Silva LDP; Colloza-Gama GA; Bastos AU; Delcelo R; Oler G; Cerutti JM
Front Endocrinol (Lausanne); 2021; 12():643151. PubMed ID: 33776938
[TBL] [Abstract][Full Text] [Related]
16. Survival of patients with malignant primary osseous spinal neoplasms: results from the Surveillance, Epidemiology, and End Results (SEER) database from 1973 to 2003.
Mukherjee D; Chaichana KL; Gokaslan ZL; Aaronson O; Cheng JS; McGirt MJ
J Neurosurg Spine; 2011 Feb; 14(2):143-50. PubMed ID: 21184634
[TBL] [Abstract][Full Text] [Related]
17. The correlations between DNA methylation and polymorphisms in the promoter region of the human telomerase reverse transcriptase (hTERT) gene with postoperative recurrence in patients with thyroid carcinoma (TC).
Li JJ; Zheng PCJ; Wang YZ
World J Surg Oncol; 2017 Jun; 15(1):114. PubMed ID: 28587656
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of telomerase-associated parameters in glioblastoma: effect of patient age.
Lötsch D; Ghanim B; Laaber M; Wurm G; Weis S; Lenz S; Webersinke G; Pichler J; Berger W; Spiegl-Kreinecker S
Neuro Oncol; 2013 Apr; 15(4):423-32. PubMed ID: 23393205
[TBL] [Abstract][Full Text] [Related]
19. TERT promoter mutations and long telomere length predict poor survival and radiotherapy resistance in gliomas.
Gao K; Li G; Qu Y; Wang M; Cui B; Ji M; Shi B; Hou P
Oncotarget; 2016 Feb; 7(8):8712-25. PubMed ID: 26556853
[TBL] [Abstract][Full Text] [Related]
20. hTERT Is highly expressed in Ewing's sarcoma and activated by EWS-ETS oncoproteins.
Fuchs B; Inwards C; Scully SP; Janknecht R
Clin Orthop Relat Res; 2004 Sep; (426):64-8. PubMed ID: 15346053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
